4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-057696
Director sold 21,374 shares at $36.38 ($777,586)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gallagher Carol Giltner Director | 2018-11-07 | Sale | −21,374 | $36.38 | $777,586 | 88,818 | D: show line 1 in the form |
| Open-market sales · 21,374 sh · avg $36.38 · $777,586 | |||||||
Loading xslF345X03/doc4.xml…